Tumour Seeding After a Thoracic Biopsy for Renal Cell Carcinoma: A Case Report and a Review of the Literature.

Neoplasm seeding percutaneous biopsy complications renal cell carcinoma

Journal

Clinical Medicine Insights. Oncology
ISSN: 1179-5549
Titre abrégé: Clin Med Insights Oncol
Pays: United States
ID NLM: 101525771

Informations de publication

Date de publication:
2021
Historique:
received: 03 11 2020
accepted: 10 05 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 3 7 2021
Statut: epublish

Résumé

The role of percutaneous tumour biopsies had gain importance in the management of renal cell carcinoma to provide diagnostic specimen for the patients with metastatic disease that could benefit a systemic treatment. Among the possible complications of this procedure, however, there is the risk of tumoral cells seeding along the biopsy's tract; this complication, albeit being reported as anecdotal, could have devastating effects. Here we report a case of a young male who developed subcutaneous chest metastasis of renal cell carcinoma after a biopsy of a lung nodule. We subsequently reviewed other cases reported in literature.

Identifiants

pubmed: 34211307
doi: 10.1177/11795549211022261
pii: 10.1177_11795549211022261
pmc: PMC8216389
doi:

Types de publication

Case Reports

Langues

eng

Pagination

11795549211022261

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© The Author(s) 2021.

Déclaration de conflit d'intérêts

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

J Thorac Imaging. 1998 Jan;13(1):2-6
pubmed: 9440831
Korean J Urol. 2015 Sep;56(9):666-9
pubmed: 26366280
N Engl J Med. 2012 Mar 8;366(10):883-892
pubmed: 22397650
Eur Urol. 2016 Apr;69(4):660-673
pubmed: 26323946
J Vasc Interv Radiol. 2013 Sep;24(9):1404-8
pubmed: 23973027
Diagn Cytopathol. 2014 Jul;42(7):636-40
pubmed: 24591300
Immunotherapy. 2019 Jan;11(1):21-35
pubmed: 30702014
Diagn Cytopathol. 2013 May;41(5):470-2
pubmed: 22241751
BMJ Case Rep. 2014 Apr 30;2014:
pubmed: 24788630
J Urol. 1986 Dec;136(6):1292-3
pubmed: 3773108
J Urol. 1986 Aug;136(2):446-8
pubmed: 3735515
J Gastroenterol Hepatol. 1993 Mar-Apr;8(2):195-8
pubmed: 8386023
N Engl J Med. 2018 Aug 02;379(5):417-427
pubmed: 29860937
Thyroid. 2006 Oct;16(10):1059-62
pubmed: 17042694
Can Urol Assoc J. 2015 Nov-Dec;9(11-12):E890-3
pubmed: 26834899
Acad Radiol. 2015 Apr;22(4):481-7
pubmed: 25601302
Dermatol Online J. 2010 Feb 15;16(2):10
pubmed: 20178706
Eur J Ultrasound. 2002 Jun;15(1-2):65-8
pubmed: 12044855
Urol Oncol. 2018 Dec;36(12):527.e13-527.e19
pubmed: 30228094
Eur J Radiol. 2006 Jul;59(1):60-4
pubmed: 16530369
J Urol. 1977 Nov;118(5):865-7
pubmed: 916121
Can Urol Assoc J. 2013 Mar-Apr;7(3-4):E176-9
pubmed: 23589753
J Vasc Interv Radiol. 2003 Sep;14(9 Pt 2):S199-202
pubmed: 14514818
JAMA Oncol. 2019 Feb 1;5(2):164-170
pubmed: 30543350
Urol Case Rep. 2018 Nov 15;23:32-33
pubmed: 30534526
Eur Urol. 2019 May;75(5):861-867
pubmed: 30591353
J Urol. 2007 Aug;178(2):379-86
pubmed: 17561170
Liver Int. 2007 Mar;27(2):192-200
pubmed: 17311613
Ann Oncol. 2019 May 1;30(5):706-720
pubmed: 30788497
Urol Case Rep. 2016 Sep 25;9:43-4
pubmed: 27679761
Case Rep Urol. 2015;2015:925254
pubmed: 26290768

Auteurs

Dionese Michele (D)

Oncology Unit 1, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy.
Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.

Basso Umberto (B)

Oncology Unit 1, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy.

Ramondo Gaetano (R)

Radiology Unit, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy.

Pierantoni Francesco (P)

Oncology Unit 1, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy.

Bimbatti Davide (B)

Oncology Unit 1, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy.

Caumo Francesca (C)

Radiology Unit, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy.

Vittorina Zagone (V)

Oncology Unit 1, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy.

Maruzzo Marco (M)

Oncology Unit 1, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy.

Classifications MeSH